Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD)

BACKGROUND: The androgen receptor (AR) is a key oncogenic driver of prostate cancer, and has been the primary focus of prostate cancer treatment for several decades. We have previously demonstrated that the AR is also an immunological target antigen, recognized in patients with prostate cancer, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Prostate
Asıl Yazarlar: Olson, Brian M., Bradley, Eric, Sawicki, Thomas, Zhong, Weixiong, Ranheim, Erik A., Bloom, Jordan, Colluru, Viswa, Johnson, Laura, Rekoske, Brian, Eickhoff, Jens C., McNeel, Douglas G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382038/
https://ncbi.nlm.nih.gov/pubmed/28181678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23321
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller